Bone Biologics Corporation (BBLG) Net margin 2016–2020
Bone Biologics Corporation (BBLG) net profit margin by fiscal year — reported net income divided by reported revenue.
-0.2%FY2020 · since FY2016: -2.4% → -0.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2020 | -0.2% | +0.1 pp |
| FY2019 | -0.3% | — |
| FY2016 | -2.4% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More BBLG financial trends
BBLG RevenueBBLG Net incomeBBLG Gross profitBBLG Gross marginBBLG Operating incomeBBLG Operating marginBBLG Operating cash flowBBLG Free cash flowBBLG Capital expendituresBBLG Return on equityBBLG Stock buybacksBBLG Dividends paidBBLG Total assetsBBLG Total liabilitiesBBLG Shareholders’ equityBBLG overview →